ScreenerHero
NYXHNyxoah S.A.
EBR · BE · Healthcare · Medical Instruments & Supplies · nyxoah.com
1.446EUR0.00%Mkt Cap: 157.29M $P/E: —

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for …

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1

Key Statistics

Company
Market Cap157.29M $
Enterprise Value116.20M $
Revenue (TTM)23.55M $
Gross Profit6.88M $
Net Income (TTM)-97.92M $
Revenue/Share0.5293 USD
Last Price1.446 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees153
CountryBE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.08
PEG—
EV/EBITDA-1.29
EV/Revenue4.94
P/S6.68
P/B1.74
EPS (TTM)-2.19
EPS (Forward)-0.47
52W Range
1.1406% of range6.360
52W High6.360 EUR
52W Low1.140 EUR
Profitability
Gross Margin63.13%
Oper. Margin-268.25%
EBITDA Margin0.00%
Profit Margin-899.05%
ROE-183.36%
ROA-76.04%
Growth
Revenue Growth472.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.98M $
CapEx (TTM)4.10M $
FCF Margin-212.62%
FCF Yield-31.83%
Net Debt-41.08M $
Net Debt/EBITDA0.46
Balance Sheet
Debt/Equity0.82
Current Ratio2.38
Quick Ratio2.28
Book Value/Sh0.8300 EUR
Cash/Share0.9770 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.300 EUR
Upside (mean)+266.5%
Target Range2.000 EUR – 8.300 EUR
€2.000+266.5% to mean€8.300
# Analysts3
Ownership
Shares Out.100.07M
Float50.88M
Insiders33.78%
Institutions30.43%
Technical
SMA 501.403 (+3.1%)
SMA 2002.908 (-50.3%)
Beta0.95
S&P 52W Chg18.16%
Avg Vol (30d)182.53K
Avg Vol (10d)271.71K
Technical Indicators
RSI (14)55.9
MACD-0.0064
MACD Signal-0.0406
MACD Hist.+0.0342
BB Upper1.492 EUR
BB Middle1.316 EUR
BB Lower1.141 EUR
BB Width26.67%
ATR (14)0.0818 EUR
Vol Ratio (20d)0.27x